Results 31 to 40 of about 58,004 (309)

Validasi Metode Analisis Ofloksasin dalam Plasma In Vitro secara Kromatografi Cair Kinerja Tinggi-Fluoresensi Mengacu pada European Medicines Agency Guideline

open access: yesPharmaceutical Sciences and Research, 2016
Ofloxacin is an antibiotic from second generation of fluoroquinolone's group. Concentration of ofloxacin in human plasma is low, so it requires a selective, accurate, sensitive method for analysis it.
Letitia Tania   +2 more
doaj   +1 more source

Enantioselective Extraction of Ofloxacin Enantiomers Using Ester Alcohol L-Tartarate as Chiral Selector [PDF]

open access: yesIranian Journal of Chemistry & Chemical Engineering, 2009
The distribution behavior of ofloxacin enantiomers was examined in the aqueous and organic solvent of a two-phase system containing chiral selector L-tartarate.
Xiaoqing Chen Feipeng Jiao, Xinyu Jiang
doaj  

BiOCl Decorated NaNbO3 Nanocubes: A Novel p-n Heterojunction Photocatalyst With Improved Activity for Ofloxacin Degradation

open access: yesFrontiers in Chemistry, 2018
BiOCl/NaNbO3 p-n heterojunction photocatalysts with significantly improved photocatalytic performance were fabricated by a facile in-situ growth method.
Jingjing Xu   +5 more
doaj   +1 more source

Investigation of a Truncated Aptamer for Ofloxacin Detection Using a Rapid FRET-Based Apta-Assay

open access: yesAntibiotics, 2020
In this work, we describe the use of a new truncated aptamer for the determination of ofloxacin (OFL), being a principal quinolone commonly used in both human and animal healthcare.
Sondes Ben Aissa   +4 more
doaj   +1 more source

Giant subcutaneous granuloma annulare

open access: yesClinical Dermatology Review, 2021
Subcutaneous granuloma annulare is an uncommon, benign self-limiting cutaneous disease, almost exclusively seen in young children. We report a case of 31-year-old male patient, presented with asymptomatic firm plaques over the left lateral malleoli and ...
M R Harish   +3 more
doaj   +1 more source

In-vitro activity of ofloxacin, levofloxacin and D-ofloxacin against staphylococci [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 1996
The in-vitro activity of levofloxacin was compared with ofloxacin and D-ofloxacin against 130 isolates of Staphylococcus aureaus and 117 isolates of coagulase-negative staphylococci, using the agar dilution method. In general, levofloxacin was equally active or up to fourfold more active than ofloxacin against all staphylococci, including 61 ...
Georg Peters, C. von Eiff
openaire   +3 more sources

Detecting Efflux Pumps Genes in the Fluoroquinolones Resistant and Sensitive Strains of Escherichia coli in Patients with Urinary Tract Infection in Qom, Iran

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Qum, 2021
Background and Objectives: Efflux pumps are among the main mechanisms for antibiotic resistance in Escherichia coli (E.coli) strains. The present study aimed to investigate the relationship between 5 efflux pump genes; acrA, acrB, emrA, emrB, and mdtk ...
Ebrahim Eshaghi   +5 more
doaj  

Synthesis, anti-tuberculosis activity and QSAR study of 2,4-diarylquinolines and analogous polycyclic derivatives [PDF]

open access: yes, 2019
The multicomponent syntheses of 2,4-di-aryl-quinolines and analogous polycyclic derivatives as anti-tuberculosis agents were described. They were prepared via Beyer and Friedländer methods under microwave irradiation in short reaction times and good ...
Asís, Silvia Elizabeth   +7 more
core   +1 more source

Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones. [PDF]

open access: yes, 2014
BackgroundTo determine the relationship between type three secretion genotype and fluoroquinolone resistance for P. aeruginosa strains isolated from microbial keratitis during the Steroids for Corneal Ulcers Trial (SCUT) and for two laboratory strains ...
Acharya, Nisha R   +9 more
core   +4 more sources

Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis.

open access: yes, 2003
PURPOSE: To compare the efficacy and safety of ofloxacin 0.3% ophthalmic solution with ciprofloxacin 0.3% ophthalmic solution in patients with culture-positive bacterial keratitis.
George, C   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy